Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / week in review fosun acquires verimmune cancer immun

LEGN - Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal

Legend Biotech Corporation
  • Fosun Pharma acquired China rights to a novel broad cancer immunotherapy candidate from VerImmune of Baltimore in a $125 million agreement.
  • Oncotelic Therapeutics, a South San Francisco company, formed a Hong Kong JV with Dragon Overseas Capital to develop TGF-? therapeutics.
  • Legend Biotech was approved to launch its CAR-T therapy, Carvykti, in Europe for patients with multiple myeloma.
  • Tianjin CanSino Biologics reported its novel recombinant coronavirus vaccine, Convidecia, was approved for Emergency Use by WHO.

For further details see:

Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
Stock Information
Company Name: Legend Biotech Corporation
Stock Symbol: LEGN
Market: NASDAQ
Menu
LEGN LEGN Quote LEGN Short LEGN News LEGN Articles LEGN Message Board
Get LEGN Alerts

News, Short Squeeze, Breakout and More Instantly...